We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Switch from etanercept to efalizumab in a psoriatic patient with HCV infection: a case report.
- Authors
PRIGNANO, F.; ZANIERI, F.; MILANI, S.; LOTTI, T.
- Abstract
Psoriasis vulgaris is a chronic dermatosis and is a widespread dematological disease. The most represented lesions are erythemato-squamous plaques with a tendency to cover large body areas with a great impairment of normal activities and a poor quality of life. Very often psoriasis is associated to other illnesses and the dermatologist has to be aware that comorbidities have to be taken in account for a successfull treatment of the disease. We report a case of a patient affected by severe psoriasis and HCV infection. He underwent a first treatment with etenarcept with good clinical results and no change of his viral load. When etenarcept became ineffective, he received efalizumab, with a good control of his dermatological condition and a reduction of the viral load.
- Subjects
CASE studies; ETANERCEPT; EFALIZUMAB; PSORIASIS treatment; HEPATITIS C virus
- Publication
Dermatologic Therapy, 2009, Vol 22, Issue 4, p386
- ISSN
1396-0296
- Publication type
Article
- DOI
10.1111/j.1529-8019.2009.01251.x